Authors' recommendations: Hyperhidrosis is the medical term for excessive sweating, most commonly affecting the palms of the hands, soles of the feet and the axillae (armpits). Although hyperhidrosis is not life-threatening, it increases the risk of skin infections and has a significant impact on the quality of life of those affected. Botulinum toxin A is a treatment which can reduce sweating in people with hyperhidrosis. It is injected directly into the skin of the armpit, blocking the nerves in the skin that trigger sweating. Botulinum toxin A has been studied and has been found to be safe and effective in treating people with hyperhidrosis. If this formulation of botulinum toxin A (Dysport) is licensed for axillary hyperhidrosis, it will provide an additional treatment option for people with this distressing condition.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/botulinum-toxin-a-dysport-for-hyperhidrosis-of-the-axillae/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)